Frankincense Intense Age Defying Eye Cream 15g

Product Details
PLU 1180
£50.00

Out of Stock - please contact your consultant

  • 92%* agreed the skin around their eyes feels smooth

    84%* agreed the skin around their eyes looks brighter

    NEW & IMPROVED FORMULA

    Clinically proven to reduce puffiness, dark circles and fine lines around the eyes, our organic and age-defying eye cream visibly reduces some of the first signs of ageing. A plant-based 3-peptide complex and gardenia stem cells work with hyaluronic acid to provide multi-level protection for the collagen network, enhancing skin plumpness and hydration. Caffeine from green tea extract reduces the appearance of dark circles and puffiness, while nourishing oils and emulsifiers create a unique cushion-like texture, ideal for the delicate eye area. The eye area is left noticeably smoother and brighter.

    AT A GLANCE

    • Clinically proven to reduce puffiness, dark circles and fine lines and wrinkles around the delicate eye area
    • With plant-based peptides and hyaluronic acid to enhance skin plumpness and hydration
    • Suitable for all skin types and tones
    • Certified organic, vegan-friendly and cruelty-free

    WHAT'S CHANGED?

    • We’ve added a new and powerful plant-based peptide derived from quinoa seed extract, which helps to visibly reduce under eye bags and puffiness
    • A combination of naturally derived emulsifiers and nourishing oils delivers a more luxurious feel upon application
    • Now certified vegan-friendly

    STRESS LESS

    Used in meditation practices for thousands of years, inhaling the therapeutic aroma of frankincense while applying the serum can help transform your skincare routine into a moment of mindfulness.

    DID YOU KNOW?

    Skin is more delicate around the eye area, which is why our formulators designed this cream with a unique cushion-like texture. A little goes a long way!

    Warning: Avoid contact with eyes. Avoid use in case of known allergy to listed ingredients.

    From a consumer trial with 107 participants over 4 weeks